AstraZeneca, makers of Nexium, America's favorite and best selling purple pill is applying for a dosage appropriate pill for infants from birth to 1 year old with chronic GERD (gastroesopheagal reflex disease).
The treatment would be for up to 6 weeks.
Although physiologic non-painful regurgitation is normal in the first year of life, some infants may have persistent symptoms diagnosed as GERD that could require treatment with an acid-suppressive drug to help resolve the problem.
What next? Baby-strength Lipitor?